SGLT inhibitors for treating type 1 diabetes: NICE technology appraisals TA597 and TA622 | GPnotebook TV

This site is intended for UK healthcare professionals

GPnotebook ↗︎
GPnotebook Podcast ↗︎
blank
×

SGLT inhibitors for treating type 1 diabetes: NICE technology appraisals TA597 and TA622

12 June 2020
Dr David Millar-Jones summarises the key points for primary care relating to use of sodium–glucose cotransporter inhibitors in people with type 1 diabetes.

Categories

Tags

blank

The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

© Oxbridge Solutions Ltd, 2023

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.